Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
sábado, octubre 24
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
HCA Healthcare Inc
HCA
NYSE
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$469.03
1.72
0.37%
Últ. Act.: Oct 23, 4:00 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Dividendos
Comparar
Opciones
Informe de acciones
Ganancias:
Beneficios de Q3 2026 dentro de 3 días de ahora en mar oct 27th, antes de la apertura del mercado
Conferencia telefónica:
Conferencia telefónica programada para dentro de 3 días a las 10:00 a. m.
Haz clic para ver el webcast
HCA Healthcare Financials
HCA Healthcare (HCA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Behind HCA's Q2 Beat: One-Time Medicaid Boost and a Growing Insurance Headwind
HCA's Q2 results beat expectations. Company resets 2026 guidance on HIX headwinds and decline in surgeries.
Priya Nigam
HCA Healthcare Analysts Slash Their Forecasts After Q2 Results
HCA Healthcare's Q2 earnings beat expectations with $20.23B in revenue and adjusted earnings of $7.59 per share. Analysts lower price targets.
Avi Kapoor
HCA Healthcare Surpasses Q2 Estimates With Strong Admissions Growth
HCA Healthcare beat Q2 revenue and earnings estimates as admissions rose, while a payer mix shift and lower surgical volumes weighed on results.
Vandana Singh
PRO
HCA Healthcare Affirms FY2026 GAAP EPS Guidance of $28.70-$30.50 vs $29.70 Est; Affirms FY2026 Sales Guidance of $77.000B-$79.500B vs $78.457B Est
HCA Healthcare (NYSE:HCA) affirms FY2026 GAAP EPS guidance from $28.70-$30.50 to $28.70-$30.50 vs $29.70 analyst estimate. Affirms FY2026 sales outlook from $77.000 billion-$79.500 billion to $77.000 billion-$79.500
Benzinga Newsdesk
PRO
HCA Healthcare Q2 Adj. EPS $7.59 Beats $7.02 Estimate, Sales $20.230B Beat $19.400B Estimate
HCA Healthcare (NYSE:HCA) reported quarterly earnings of $7.59 per share which beat the analyst consensus estimate of $7.02 by 8.12 percent. This is a 10.96 percent increase over earnings of $6.84 per share from the
Benzinga Newsdesk
Earnings Scheduled For July 24, 2026
Companies Reporting Before The Bell • Charter Communications (NASDAQ:CHTR) is likely to report quarterly earnings at $10.19 per share on revenue of $13.53 billion. • American Express (NYSE:AXP) is expected to report
Benzinga Insights
